Shareholder Communications With Directors Policy
Adopted on February 19, 2008
PURE Bioscience (the “Company”) believes that it is good corporate practice to ensure that the views of the Company’s shareholders are communicated to the Company and that appropriate responses are provided to the shareholders. Shareholders can communicate with the Company by contacting Donna Singer at PURE Bioscience, 1725 Gillespie Way, EL CAJON, CA 92020, or by requesting an investor relations packet through our website at www.purebio.com.
Shareholders may also communicate appropriately with any and all Company directors by sending written correspondence addressed as follows:
Donna Singer
Executive Vice President
PURE Bioscience
1725 Gillespie Way
El Cajon, CA 92020
The Executive Vice President shall maintain a log of all correspondence so received and will deliver as soon as practicable such correspondence to the identified director addressee(s). The correspondence will not, however, be delivered if there are safety, security, appropriateness or other concerns that mitigate against delivery of the correspondence, as determined by the Executive Vice President in consultation with legal counsel. The Board or individual directors so addressed shall be advised of any correspondence withheld. The Board or individual director, as applicable, will generate an appropriate response to all validly received shareholder correspondence and will direct the Executive Vice President to send the response to the particular shareholder.